IOT
IOT
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
9
$65.82M
Total Volume
$65.82M
75 transactions
Net Activity
$65.82M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Biswas Sanjit
CEO, 10%
$32.11M total
Bicket John
See remarks, 10%
$32.11M total
Phillips Dominic
See remarks
$1.23M total
Eltoukhy Adam
See remarks
$285K total
Kirchhoff Benjamin Louis
CHIEF ACCOUNTING OFFICER
$87K total
Quick Actions
IOT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. IOT ranks #84 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at IOT (IOT) engaged in a total of 75 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 9 were sales. The total volume of insider trading reached $65.82M.
The net insider activity for IOT shows a net selling bias of $65.82M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Biswas Sanjit (CEO, 10%), who traded 263.9K shares valued at $11.33M on Oct 27, 2026.
Is Samsara (IOT) Undervalued After Its AI Product Push In Europe?
Samsara chief accounting officer sells $31,062 in IoT shares By Investing.com
Samsara Inc. (NYSE:IOT) Stock Has Average Price Target of $51.32
6 Best Internet of Things Stocks for 2026 and How to Invest
Under a trading plan, Samsara (IOT) accounting chief Benjamin Louis Kirchhoff sold 792 shares.
Samsara Inc. (IOT) Stock Moves -4.02%: What You Should Know
Related News & Analyst Reports
Read original insights and educational research covering IOT and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
Tracking Insider Activity in Biotech: High Stakes and Hidden Signals
Biotech insiders possess unique asymmetric information, clinical results, FDA feedback, partnership negotiations. This guide explains how to track Form 4 activity at pre-commercial biotechs, what position sizes matter, and how to avoid false signals near data events.
Venture-Backed Biotech IPOs: Inside the 2026 Buying Spree
2026 saw a resurgence of venture-backed biotech IPOs, accompanied by unusually high post-lockup insider buying. This report documents the specific Form 4 cluster events, purchase sizes, and 90-day price performance across a dozen recent biotech offerings.
Biotech Insider Buying: Analyzing Clinical Trial Catalysts
Biotech insiders walk a legal tightrope near trial readouts. This report identifies statistically significant buying clusters at small-cap biotechs 30-90 days before Phase 2 and Phase 3 data announcements.
Why Biotech Insiders Purchase Prior to Phase 3 Results
Buying stock before Phase 3 results is the highest-risk insider trade in biotech. This report examines the legal boundaries, the statistical frequency of such purchases, and whether insiders who buy pre-Phase-3 have historically outperformed those who buy after.
Analyzing the Correlation Between R&D Spending and Insider Confidence
Do executives buy more stock when R&D budgets surge? This study correlates quarterly R&D expenditure disclosures with insider purchase timing across 200 tech and biotech companies from 2020-2025.
FAQs About IOT Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for IOT.